Vaccinex (VCNX) shares will be delisted from the Nasdaq stock exchange on Wednesday after the company failed to comply with the market's rule of maintaining a minimum of $2.5 million in stockholders' equity, Vaccinex said Tuesday, citing a notification from the exchange's Office of General Counsel.
The company said it expects to begin trading on the OTC Markets under its current symbol "VCNX" after the Nasdaq suspension.
Price: 1.91, Change: -1.81, Percent Change: -48.66
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。